GHP extends management contract in UAE

GHP is extending its very successful collaboration with the Ministry of Health
(MoH) in the United Arab Emirates (UAE) by entering into an extension of its
current management contract. The extension means that GHP will continue to run
the Rashid Center for Diabetes and Research for at least another two years.
GHP’s diabetes centre in Ajman, the Rashid Center for Diabetes and Research,
started in 2010 and contains several different clinics, all of which aim at
improving the life of diabetics in the United Arab Emirates. The centre
comprises a diabetes clinic, an obesity clinic, a lifestyle clinic,
physiotherapy, a foot clinic, an ophthalmology clinic, a dental clinic,
cardiology, neurology and a laboratory. Nearly 30,000 patient appointments and
more than 225,000 laboratory tests were carried out during 2014.

The centre is the national reference centre for diabetes and obesity treatment
and a centre of excellence for all of the GCC. Moreover, extensive research is
carried out in a number of areas and employees at the clinic have published a
large number of research reports in recent years.

“It is most gratifying that GHP can continue its work at the Rashid Center of
improving the quality of life of diabetes patients in the UAE by combining
modern diabetes care with research and education of the local population,” says
Bengt Ternström, the clinic’s General Manager.

It is estimated that approximately 20 percent of the population in the United
Arab Emirates suffers from diabetes, mainly caused by obesity and overweight.
GHP sees potential for continued business development in the region, not least
in the diabetes diagnostic area.

5 February 2015
Gothenburg, Sweden
Global Health Partner AB (publ)
Queries should be addressed to:
Daniel Öhman, CEO, Tel: +46 708 55 37 07
Tobias Linebäck, CFO and Head of Investor Relations, Tel: +46 708 55 37 19
GHP is an internationally active health care provider that operates specialist
clinics in a select number of diagnostic areas through the application of a
business model that is unique in the health care industry, where leading doctors
become partners and shareholders. Multiple clinics with high patient volumes
within the same diagnostic area produce increased efficiency and higher quality,
which is the cornerstone of GHP's business philosophy – “Quality through
specialisation”. GHP shares are traded on the Small Cap list of NASDAQ OMX
Stockholm under the ticker symbol “GHP”.

Global Health Partner AB (publ) | Corp. ID No. 556757-1103
Södra Hamngatan 45 | SE-411 06 Gothenburg | Sweden
Tel 46-31 712 53 00 | Fax 46-31 313 13 21 | www.ghp.se

This is a translation of the Swedish version of the press release. When in
doubt, the Swedish wording prevails.